感染性心内膜炎住院患者急性肾损伤的危险因素及预测价值
该回顾性研究纳入402例成人感染性心内膜炎住院患者,最终290例纳入分析,其中92例发生AKI(31.7%)。AKI组住院死亡率显著高于非AKI组(30.4% vs 8.6%,P<0.01),且AKI 2-3期死亡率高于1期(43.5% vs 17.4%,P<0.01)。多因素Logistic回归显示基础eGFR低(HR=0.136)、脓毒症(HR=6.100)、需用NSAIDs(HR=2.990)和造影剂(HR=3.153)为独立危险因素。基于上述因素构建的预测模型ROC曲线AUC为0.888,灵敏度86.4%,特异度80.9%。
要点
- 感染性心内膜炎住院患者AKI发生率为31.7%,AKI组住院死亡率30.4% vs 非AKI组8.6%(P<0.01)。
- AKI 2-3期患者住院死亡率43.5% vs AKI 1期17.4%(P<0.01)。
- 基础eGFR低(HR=0.136,95%CI 0.066-0.280)、脓毒症(HR=6.100,95%CI 2.394-15.543)、需用NSAIDs(HR=2.990,95%CI 1.184-7.546)、造影剂(HR=3.153,95%CI 1.207-8.238)为独立危险因素。
- 基于上述危险因素的预测模型AUC为0.888(95%CI 0.833-0.943,P<0.01),灵敏度86.4%,特异度80.9%。
适用人群与场景
- 2010年1月至2020年1月青岛大学附属医院收治的402例确诊感染性心内膜炎成人住院患者,最终290例纳入分析。
红旗征与不能漏的情况
- 感染性心内膜炎住院患者出现脓毒症、需使用NSAIDs或造影剂、基础eGFR低时,AKI风险显著升高,AKI组住院死亡率30.4% vs 非AKI组8.6%(P<0.01)。
研究设计与关键结果
- 回顾性分析290例感染性心内膜炎住院患者,AKI发生率为31.7%(92/290),其中AKI 1期46例(50.0%),AKI 2-3期46例(50.0%)。
- AKI组较非AKI组年龄更大[64(55,71)岁 vs 55(46,63)岁],基础eGFR更低(64.6±13.6 vs 82.9±19.5 mL×min-1×1.73m-2),糖尿病比例更高(16.3% vs 8.6%),脓毒症发生率更高(38.0% vs 13.1%),ACEI/ARB使用更多(25.0% vs 15.2%),利尿剂使用更多(82.6% vs 63.1%),NSAIDs使用更多(58.7% vs 24.2%),尿
- AKI组住院死亡率30.4% vs 非AKI组8.6%(P<0.01);AKI 2-3期住院死亡率43.5% vs AKI 1期17.4%(P<0.01)。
- 多因素Logistic回归:基础eGFR低(HR=0.136,95%CI 0.066-0.280)、脓毒症(HR=6.100,95%CI 2.394-15.543)、需用NSAIDs(HR=2.990,95%CI 1.184-7.546)、造影剂(HR=3.153,95%CI 1.207-8.238)为AKI独立危险因素(均P<0.05)。
- 基于上述危险因素构建的预测模型AUC为0.888(95%CI 0.833-0.943,P<0.01),灵敏度86.4%,特异度80.9%。
证据类型、等级与局限
- 证据类型:单中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对感染性心内膜炎住院患者,应关注基础eGFR低、脓毒症、需用NSAIDs和造影剂等AKI危险因素;预测模型对AKI发生有一定预测价值(AUC=0.888)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze the risk factors of acute kidney injury (AKI) in hospitalized patients with infective endocarditis (IE), construct prediction model, and discuss its predictive value.
METHODS: The clinical data of 402 adult inpatients diagnosed with IE admitted to the Affiliated Hospital of Qingdao University from January 2010 to January 2020 were retrospectively analyzed. The patients were divided into the AKI group and the non-AKI group. The clinical data, such as gender, age, presence of diabetes, basic estimated glomerular filtration rate (eGFR), laboratory indexes at admission, involvement of valves, presence of sepsis, medication during hospitalization, surgery and outcome of the two groups were compared. Multivariate Logistic regression analysis was used to screen the risk factors of AKI in IE inpatients. A predictive model was constructed, and receiver operating characteristic (ROC) curve was used to analyze the predictive value of the model.
RESULTS: A total of 290 patients with IE were enrolled, including 198 non-AKI patients and 92 AKI patients. The incidence of AKI was 31.7%. Among the 92 AKI patients, 46 patients were at AKI stage 1 (50.0%), while 46 patients were at AKI stage 2 and stage 3 (50.0%). Compared with the non-AKI group, patients in the AKI group were older [years old: 64 (55, 71) vs. 55 (46, 63)], and had lower basic eGFR (mL×min-1×1.73 m-2: 64.6±13.6 vs. 82.9±19.5), higher proportion of diabetic and incidence of sepsis (16.3% vs. 8.6%, 38.0% vs. 13.1%), more frequent use of angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists (ACEI/ARB), diuretics and non-steroidal anti-inflammatory drugs (NSAIDs; 25.0% vs. 15.2%, 82.6% vs. 63.1%, 58.7% vs. 24.2%), more abnormal urine test results (hematuria or proteinuria, 35.9% vs. 22.7%), higher pathogen culture negative rate (73.9% vs. 51.5%), lower Gram positive (G+) cocci infection rate and surgery rate (22.8% vs. 40.4%, 60.9% vs. 81.8 %), with significant differences (all P < 0.05). There were no significant differences in the gender, number and location of involved valves, and laboratory indexes at admission between the two groups. Compared with the non-AKI group, the inpatient mortality rate of the AKI group was higher (30.4% vs. 8.6%, P < 0.01), and the inpatient mortality rate of patients with AKI stage 2 and stage 3 was significantly higher than that of patients with AKI stage 1 (43.5% vs. 17.4%, P < 0.01). In multivariate Logistic regression analysis, the lower basic eGFR [hazard ratio (HR) = 0.136, 95% confidence interval (95%CI) was 0.066-0.280], sepsis (HR = 6.100, 95%CI was 2.394-15.543), demand for NSAIDs (HR = 2.990, 95%CI was 1.184-7.546) and radiocontrast agent (HR = 3.153, 95%CI was 1.207-8.238) were independent risk factors for AKI in hospitalized patients with IE (all P < 0.05). A prediction model was constructed based on the above risk factors, and ROC curve analysis showed that the area under the ROC curve (AUC) of prediction model for AKI was 0.888 (95%CI was 0.833-0.943, P < 0.01) with sensitivity of 86.4% and specificity of 80.9%.
CONCLUSIONS: In the IE-susceptible population, low basic eGFR, sepsis, the need for NSAIDs and contrast agent are independent risk factors to AKI. The predictive model constructed by the above risk factors has certain predictive value for the occurrence of AKI in the IE inpatients.
参考来源
- Zhang W, Xue F, Li H, et al. [Risk factors of acute kidney injury in hospitalized patients with infective endocarditis and their predictive values]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33081893. doi:10.3760/cma.j.cn121430-20200630-00497
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。